首页> 外国专利> Crystalline compound (r)-5-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethyl-8-hydroxy-1h-quinolin-2-one acetate, dry powder pharmaceutical compositions comprising same and use thereof for the preparation of medicaments for the treatment of asthma or chronic obstructive pulmonary disease

Crystalline compound (r)-5-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethyl-8-hydroxy-1h-quinolin-2-one acetate, dry powder pharmaceutical compositions comprising same and use thereof for the preparation of medicaments for the treatment of asthma or chronic obstructive pulmonary disease

机译:结晶化合物(r)-5- [2-(5,6-二乙基-茚满-2-基氨基)-1-羟乙基] -8-羟基-1h-喹啉-2-酮乙酸盐,包含其的干粉药物组合物和其在制备用于治疗哮喘或慢性阻塞性肺疾病的药物中的用途

摘要

Compounds of formula I in salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 and A have the meanings as indicated in the specification, are useful for treating diseases mediated by the 2-adrenoreceptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
机译:盐或溶剂化物形式的式I化合物可用于治疗由2介导的疾病,其中W,Rx,Ry,R1,R2,R3,R4,R5,R6和R7和A具有本说明书中所述的含义。 -肾上腺素受体。还描述了包含所述化合物的药物组合物和制备所述化合物的方法。

著录项

  • 公开/公告号IL195796A

    专利类型

  • 公开/公告日2016-03-31

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号IL20080195796

  • 发明设计人

    申请日2008-12-08

  • 分类号A61K;

  • 国家 IL

  • 入库时间 2022-08-21 14:26:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号